Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later

Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06644976

Enrollment

100

Registered

2024-10-16

Start date

2024-08-20

Completion date

2025-12-31

Last updated

2024-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anticoagulant Therapy, Femoral Neck Fractures, Osteoperosis

Brief summary

until today we waited at least 24 hours before surgery of femoral neck fractures in patients who take anticouagolation . in our new reasearch we belive that patients who take NOAC can go under surgery earlier with minimal risk

Interventions

PROCEDUREfemoral neck CRIF

femoral neck fracture CRiF while under noac. no special intervention beside taking blood test for drug levels

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

above 18 y.o femoral neck fracture NOAC capable of making inform consent primary surgery \-

Exclusion criteria

* under 18 y.o * anti platelet therapy (aspirin is not included) * creatinine clearance under 50 * active anti cancer therapy * ITP patients * non capable of making inform consent * patients which decide not to proceed with the expeirment

Design outcomes

Primary

Measure	Time frame
bleeding	30 days

Countries

Israel

Contacts

Primary ContactMeron pinchas talmor, medical doctor

merontalmor@gmail.com+972523264183

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026